Biggest News Aggregation in the World
📰 Deutsche Bourse News

Deutsche Bourse News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Deutsche Bourse. Real-time updates on events, politics, business and more.

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

BIOVAXYS ANNOUNCES complete inhibition of ACE-2 binding activity of hapten-modified SARS-CoV-2 protein

SUGGESTS superior cardiAC safety compared to mRNA AND ADENOVIRUS VECTOR vaccines VANCOUVER, BC, Feb. 16, 2022 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAX) ("BioVaxys" or "Company") announced today that studies on BVX-0320, its haptenized SARS-CoV-2 s-spike protein vaccine, demonstrate that the vaccine does not bind to the Angiotensin Converting Enzyme-2 (ACE2) receptor. The finding...
United Kingdom British Columbia Merck Kgaa Deutsche Biovaxys Technology Corp Ohio State University Biovaxys Or Company

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science